BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27665480)

  • 1. Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival.
    Samson P; Crabtree T; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Meyers B; Puri V
    Ann Thorac Surg; 2017 Jan; 103(1):303-311. PubMed ID: 27665480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?
    Bott MJ; Patel AP; Crabtree TD; Colditz GA; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Dec; 100(6):2048-53. PubMed ID: 26277562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria.
    Osarogiagbon RU; Ray MA; Faris NR; Smeltzer MP; Fehnel C; Houston-Harris C; Signore RS; McHugh LM; Levy P; Wiggins L; Sachdev V; Robbins ET
    Ann Thorac Surg; 2017 May; 103(5):1557-1565. PubMed ID: 28366464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer.
    Toubat O; Atay SM; Kim AW; Ding L; Farias AJ; Ebner PJ; McFadden PM; David EA
    Ann Thorac Surg; 2020 May; 109(5):1512-1520. PubMed ID: 31982443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.
    Samson P; Patel A; Garrett T; Crabtree T; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Jun; 99(6):1906-12; discussion 1913. PubMed ID: 25890663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter?
    Samson P; Patel A; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Nov; 100(5):1773-9. PubMed ID: 26228601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.
    Heiden BT; Eaton DB; Engelhardt KE; Chang SH; Yan Y; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
    JAMA Netw Open; 2021 May; 4(5):e2111613. PubMed ID: 34042991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
    Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
    Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it safe to wait? The effect of surgical wait time on survival in patients with non-small cell lung cancer.
    Coughlin S; Plourde M; Guidolin K; Fortin D; Frechette E; Malthaner R; Inculet R
    Can J Surg; 2015 Dec; 58(6):414-8. PubMed ID: 26574834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer.
    Bott MJ; Patel AP; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnicka AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Jun; 99(6):1921-8. PubMed ID: 25912748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data.
    Kates M; Swanson S; Wisnivesky JP
    Chest; 2011 Mar; 139(3):491-496. PubMed ID: 20576736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate of Pneumonectomy Patients Variably Captured by Non-Small Cell Lung Cancer Staging System.
    Dhanasopon AP; Salazar MC; Hoag JR; Rosen JE; Kim AW; Detterbeck FC; Blasberg JD; Boffa DJ
    Ann Thorac Surg; 2017 Dec; 104(6):1829-1836. PubMed ID: 29074151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Surgical Timing After Neoadjuvant Therapy for Stage IIIa Non-Small Cell Lung Cancer.
    Rice JD; Heidel J; Trivedi JR; van Berkel VH
    Ann Thorac Surg; 2020 Mar; 109(3):842-847. PubMed ID: 31756320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
    Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
    Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.
    Ludwig MS; Goodman M; Miller DL; Johnstone PA
    Chest; 2005 Sep; 128(3):1545-50. PubMed ID: 16162756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.
    Speicher PJ; Gu L; Gulack BC; Wang X; D'Amico TA; Hartwig MG; Berry MF
    Clin Lung Cancer; 2016 Jan; 17(1):47-55. PubMed ID: 26602547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base.
    Yang CF; Sun Z; Speicher PJ; Saud SM; Gulack BC; Hartwig MG; Harpole DH; Onaitis MW; Tong BC; D'Amico TA; Berry MF
    Ann Thorac Surg; 2016 Mar; 101(3):1037-42. PubMed ID: 26822346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.
    Wang EH; Corso CD; Rutter CE; Park HS; Chen AB; Kim AW; Wilson LD; Decker RH; Yu JB
    J Clin Oncol; 2015 Sep; 33(25):2727-34. PubMed ID: 26101240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.